Dermal Filler Side Effects: Ordinary Bruising vs the Blanching or Pain That Needs Urgent Care

The mirror check happens at about 11 p.m. Six hours after a lip appointment, a woman tilts her chin under the bathroom light and finds a purple bloom along the left side of her upper lip. Her partner says it looks fine. Her phone says it might be a blocked artery. She does not sleep well.

Nearly everyone who has had an injectable treatment knows that small spiral of doubt. Dermal filler side effects sit on a spectrum, and the two ends look nothing alike. At one end is the ordinary bruise, which is slightly sore, changes color over a week and asks nothing of you but patience. At the other end is a blanched, painful patch of skin that means a vessel has been compromised and the clock is running.

Telling those two apart is the single most useful skill a patient can take home from the treatment room. This article is about that skill, grounded in what the medical evidence actually shows.

Which dermal filler side effects are common, and which are rare

Think of filler complications as three rings. The inner ring is what almost everyone experiences to some degree: redness at the needle marks, swelling, tenderness and bruising. Patient guidance from the NHS and the Cleveland Clinic lists these as expected, short-term effects rather than complications in the true sense. They are the body doing what it does when a needle enters skin and a gel is placed beneath it.

The middle ring holds problems that are uncommon but well described: small lumps you can feel but not see, asymmetry, filler that has settled slightly away from where it was placed, infection at the injection site, and the bluish tint that a superficially placed hyaluronic acid filler can give thin skin. Most of these are correctable, though some need a second visit or a dissolving treatment.

The outer ring is rare and serious. Filler entering or compressing a blood vessel can starve the skin of oxygen, leading to tissue death. In the worst case, filler pushed into an artery around the eye or nose can travel backward into the vessels supplying the retina and cause partial or total loss of vision. The NHS names both outcomes explicitly in its patient information. They are uncommon, but they are the reason the phrase “just a bit of filler” deserves gentle pushback.

Why does the outer ring matter so much when it is so small? Because time changes everything. A bruise gets better whether you act or not. A blocked vessel gets worse by the hour unless someone intervenes. Knowing which ring you are in is the whole game, and the rest of this article is about learning to tell.

How dermal fillers work, and why they can cause trouble

A dermal filler is a soft gel injected beneath the skin to add volume, smooth a fold or reshape a contour. The most widely used type is made from hyaluronic acid, a sugar molecule your own tissues already produce that holds many times its weight in water. Other fillers use calcium hydroxylapatite (a mineral found in bone), poly-L-lactic acid (a material that prompts your skin to build collagen over months), or permanent substances such as polymethylmethacrylate microspheres or silicone, which the body cannot break down.

The mechanism is physical rather than chemical. The gel occupies space, lifts the tissue above it and draws in water. Effects appear immediately and, according to NHS guidance, typically last around 6 to 18 months for temporary products before the material is gradually absorbed. The Cleveland Clinic gives a similar range, noting that thicker products in deeper planes tend to persist longer.

Trouble comes from geography. The face is a dense map of arteries that branch, loop and connect with one another, and several of them communicate with the vessels behind the eye. A needle or cannula (a blunt-tipped tube used as an alternative to a sharp needle) placed inside an artery can inject gel directly into the bloodstream. Gel placed next to an artery under pressure can squeeze it shut. Either way, the tissue downstream loses its oxygen supply.

The same physics explains the milder problems. Gel placed too superficially catches the light and looks blue. Gel placed unevenly feels lumpy. Gel that meets a strong muscle, especially around the lips, can be nudged over months into places it was never meant to be. None of this means fillers are inherently dangerous; it means they are a procedure performed in anatomically busy territory, and the skill and caution of the injector are the main safety variables.

Who fillers are usually for, and who is usually asked to wait

In clinical practice, fillers are used to soften deep folds such as the lines running from nose to mouth, to restore volume lost from cheeks and temples with age, to define lips, and to correct contour irregularities including some scars. The Mayo Clinic groups them among the non-surgical options for age-related skin changes, alongside botulinum toxin, resurfacing and topical treatments. They do not treat skin texture, pigment or fine surface crinkling, and a good consultation will say so.

Certain people are routinely asked to postpone or reconsider. Pregnancy and breastfeeding sit at the top of that list, not because harm has been shown but because safety data are lacking and manufacturers have not studied these groups. Active infection anywhere on the face, including a cold sore, is a reason to wait, since injecting through or near infected skin can spread it. A recent dental procedure or an upcoming one is often treated the same way, because bacteria from the mouth can seed filler and cause delayed nodules.

People with known allergy to any filler component, a history of severe scarring, or an autoimmune condition that is currently active will usually be counseled individually. Those taking medicines that affect clotting, whether prescribed anticoagulants or over-the-counter anti-inflammatories and certain supplements, are more likely to bruise; whether anything should change before treatment is a decision for the prescribing clinician, never for the injector alone and never for the patient acting independently.

Finally, injectors are trained to pause when expectations do not match what the product can deliver, or when someone appears to be seeking treatment during a period of acute distress. Waiting is not a refusal. It is often the most protective thing a practitioner can offer.

How long does filler bruising last? The first two weeks

The ordinary course is undramatic. Redness at the entry points fades within hours. Swelling peaks on the first or second day, particularly in the lips, where the tissue is loose and the blood supply generous. A lip treated in the afternoon can look noticeably fuller than intended by the next morning, and this is expected rather than a sign that too much was placed.

Bruising follows the same rules as any bruise. Blood that has leaked from tiny vessels sits under the skin and is broken down by the body in stages, shifting from red or purple to green and yellow before disappearing. Patient guidance from the Cleveland Clinic and the NHS describes bruising and swelling as typically settling within days to about two weeks, with the longer end more likely around the lips and under the eyes. Firmness or small lumps you can feel with your tongue or fingertip commonly soften over the same period as the gel integrates with the tissue.

A few features distinguish a normal bruise from something that needs attention. A bruise is tender when pressed but not painful at rest. Its color deepens and then lightens in a predictable sequence. The skin over it stays warm and pink when you press and release. It does not grow after the first day or two.

Comfort measures are simple: a cool compress in short intervals, keeping the head slightly elevated the first night, avoiding heavy exercise, alcohol and saunas for a day or two as most injectors advise, and not pressing or massaging the area unless specifically asked to. Makeup is usually fine once the needle marks have closed, which for most people is the following day.

Photographs help. Take one in the same light each morning. A bruise that looks different day to day is following the script. A patch that looks the same or worse is the one to ask about.

Filler vascular occlusion signs: blanching, pain and mottled skin

Vascular occlusion means a blood vessel has been blocked or compressed so that the tissue it supplies is no longer getting enough oxygen. In the context of filler it is rare, but it is the complication every injector is trained to recognize, and every patient should be too.

The earliest sign is often blanching: a patch of skin turning white or gray in the seconds or minutes after injection, sometimes in a pattern that follows the path of the affected artery rather than the shape of the injected area. Blanching can be brief and harmless when it is caused by the local anesthetic mixed into many fillers, which temporarily narrows small vessels. The difference is that anesthetic blanching resolves within minutes and does not hurt. Occlusion blanching persists and is followed by pain that seems out of proportion to the procedure.

Pain is the second sign, and it is a particular kind of pain: deep, aching or burning, and not relieved by the ordinary passage of time. Some people describe it as a toothache in the skin. Others notice that the treated area feels strangely numb while the surrounding area throbs.

Over the following hours the skin may take on a dusky, purplish, net-like mottling called livedo, as blood pools in the stalled vessels. This can be mistaken for a developing bruise, which is exactly why it is dangerous. A bruise is usually one uniform blotch; livedo is lacy and often extends beyond where the needle went. If the blockage is not relieved, the skin can blister, turn dark and eventually break down over days.

Any change in vision after an injection near the nose, forehead or between the eyebrows, including blurring, a shadow, double vision or pain in the eye, is a separate emergency. The evidence discussed in the next section explains why.

What is the riskiest place for fillers?

The honest answer is: the areas whose arteries connect to the eye. A review of the world literature published in Dermatologic Surgery and indexed on PubMed analyzed 98 reported cases of vision loss after filler injection. The glabella, the area between the eyebrows, accounted for 38.8 percent of cases. The nose accounted for 25.5 percent, the nasolabial folds 13.3 percent and the forehead 12.2 percent. Together those four sites explained roughly nine in ten reported cases.

Anatomy explains the pattern. Arteries around the brow, nose and inner corner of the eye are branches of the same vascular tree that feeds the retina. Gel injected under pressure into one of these branches can be pushed backward against the normal flow of blood until it reaches a junction, then carried forward into the ophthalmic circulation. The same review found that autologous fat, meaning a person’s own fat transferred by injection, was the material most often implicated, followed by hyaluronic acid. Most cases of vision loss were not reversed.

This does not mean the nose or glabella can never be treated. It means the margin for error is thinner there, and the benefit has to be weighed differently. Many practitioners decline non-surgical nose reshaping or glabellar filler altogether; others perform it only with blunt cannulas, small volumes, slow injection and constant attention to the skin’s color. The choice sits with the treating clinician, but a patient is entitled to ask why a high-risk zone is being recommended and what the plan is if something goes wrong.

Skin necrosis, tissue death without eye involvement, has a broader footprint. The lips, nose, nasolabial folds and the region around the temples are the areas most often reported. Lips deserve a special mention: they are among the most commonly treated areas and carry a large artery running roughly along the border where filler is often placed.

Dermal filler side effects at a glance: ordinary or urgent?

When you are anxious at midnight, a table is easier to read than a paragraph. The one below summarizes what patient guidance from the NHS and the Cleveland Clinic, together with the published complication literature, tells us about how to sort what you are seeing. It is a guide for deciding whether to call, not a tool for diagnosing yourself.

What you notice	Usually ordinary	Needs urgent contact
Skin color	Pink, red or a purple bruise that changes to green and yellow over a week	White, gray, or dusky purple with a lacy, net-like pattern; darkening over hours
Pain	Tender when pressed, mild ache, improving daily	Deep, burning or throbbing pain at rest, worsening, or pain out of proportion to the treatment
Timing of onset	Swelling peaks by day 1 to 2 and eases	Changes within minutes to hours after injection that persist or spread
Press test	Skin blanches on pressure and pinks up within a second or two on release	Skin stays pale after release, or refills very slowly
Vision	Unchanged	Any blurring, shadow, double vision, eye pain or headache after injection near the eyes, nose or forehead
Lumps	Small, soft, evenly distributed, softening over 1 to 2 weeks	Hot, red, enlarging or draining lumps; lumps with fever
Skin surface	Intact, perhaps with tiny needle marks	Blisters, open areas, or crusting over the treated zone

Two cautions. First, the press test is a screening trick, not proof either way: cold skin refills slowly in anyone, and early occlusion can be subtle. Second, pain has no reliable threshold. If your instinct says it is more than a sore lip, that instinct is enough reason to pick up the phone. Injectors would much rather see a false alarm than miss a real one.

Lumps, nodules and reactions that appear weeks or months later

Not every problem shows up in the first fortnight. A small group of side effects declare themselves weeks or months after treatment, when the appointment is a distant memory and the connection is not obvious.

Delayed nodules are the most discussed. These are firm, sometimes tender lumps that appear at or near an injection site long after the initial swelling has gone. Two broad explanations are recognized in the clinical literature. One is a low-grade inflammatory reaction to the gel itself, which in some people appears to be triggered by an unrelated immune challenge such as a viral illness, a dental infection or a vaccination. The other is a biofilm: a colony of bacteria, introduced at the time of injection, that lives on the surface of the filler and is protected from the body’s defenses by the gel around it. Biofilm nodules tend to be more persistent and are the reason many clinicians ask about recent dental work before injecting.

Granulomas are a distinct, rarer type of firm lump formed when immune cells wall off a material they cannot clear. They are more associated with permanent fillers such as silicone or polymethylmethacrylate, which the NHS notes cannot be removed without surgery, but they have been reported with temporary products too.

The Tyndall effect is the bluish or grayish discoloration seen when hyaluronic acid filler sits too close to the skin’s surface. It is not harmful, but it is persistent and is most common under the eyes, where the skin is thinnest.

Migration describes filler that has moved from where it was placed. It is most talked about around the lips, where the material can gradually shift above the border and blur the lip’s edge. Repeated treatments layered on partially absorbed product may make this more likely, though good comparative data are limited.

Each of these is worth reporting to the injector, who will usually want to examine the area rather than diagnose by photograph.

What are the long-term side effects of fillers?

People searching for the long term side effects of fillers deserve a plainer answer than the industry usually gives, so here it is: for temporary fillers used in modest amounts, the evidence for lasting harm is thin, but the evidence for lasting absence of harm is not as robust as many assume, because most studies follow people for months, not decades.

Several long-term observations are reasonably well supported. Hyaluronic acid filler does not always vanish on the schedule printed on the box. Imaging studies of the face performed for unrelated reasons have identified filler material persisting for years beyond the expected duration, sometimes in areas patients believed had fully reabsorbed. This does not appear to be dangerous in itself, but it means that repeated treatments may be stacking on residual product, and it may help explain the puffiness some long-term users describe.

Permanent fillers carry the clearest long-term risk. Because the body cannot break them down, any inflammatory reaction, granuloma or displacement is also permanent, and correction may require surgical excision. NHS guidance is unambiguous that permanent products carry a higher risk of complications for this reason.

Chronic or recurrent swelling, particularly under the eyes, is reported in a minority of long-term users and is thought to relate to the water-drawing property of hyaluronic acid combined with slow drainage in that area. Whether repeated filler alters the underlying tissue over decades is a question the current evidence cannot settle.

What the evidence does not support is the popular claim that fillers “stretch” the skin so that it sags when they wear off, or that they permanently damage collagen. Neither has been demonstrated in controlled studies. Absence of proof is not proof of absence, but it is a reason to treat confident warnings with the same skepticism as confident reassurances.

Are fillers more risky than botulinum toxin injections?

The two most common non-surgical facial treatments are often lumped together, but they are different in kind, and their risks are different in kind too.

Botulinum toxin is a medicine: a purified protein that temporarily blocks the signal between nerve and muscle, softening the lines caused by repeated expression. Its side effects come from that mechanism. If the medicine spreads to a muscle that was not the target, the result can be a drooping eyelid or brow, an uneven smile, or difficulty with expression, all of which resolve as the effect wears off over roughly three to four months according to Mayo Clinic guidance. Because nothing is left behind in the tissue, there is nothing to migrate, lump or block a vessel.

Fillers, by contrast, are a physical material placed near arteries. Their serious risks are vascular: skin necrosis and, rarely, vision loss. Their nuisance risks are structural: lumps, migration and asymmetry. And unlike toxin, whose effects reliably fade, some filler problems persist until they are actively treated, and permanent fillers cannot be dissolved at all.

Frequency also matters. Severe complications from cosmetic botulinum toxin at standard cosmetic doses are exceptionally rare and mostly involve spread to nearby muscles. Severe filler complications are also rare, but they carry a heavier tail: the most serious filler outcomes are permanent, while the most serious toxin outcomes in cosmetic use generally are not.

So the fair answer is that fillers carry a small but real risk of a category of harm that botulinum toxin essentially does not. That is not an argument for one over the other; they treat different things, and many people have both. It is an argument for asking different questions before each. For toxin, ask about the injector’s experience with the specific muscles. For filler, ask about the plan for a vascular event.

Why are people stopping fillers?

The question is everywhere online, and it is worth separating the evidence from the mood.

Some of the shift is aesthetic. After years of a fuller-is-better look, a visible number of people have chosen to have filler dissolved, and their stories circulate widely. Dissolving has become a treatment in its own right rather than only a rescue for complications. Many who describe stopping mention cumulative puffiness, a face that looked heavier than they wanted, or a lip border that had blurred. These accounts are consistent with the recognized effects of migration and slow-clearing product, though they are individual experiences rather than trial data.

Some of it is information. Patients now routinely encounter the regulatory warnings about vascular occlusion and blindness that once lived mostly in professional journals, and the NHS and other public bodies have expanded their patient-facing pages. People are not necessarily being frightened off; they are making a more informed calculation about whether the benefit justifies even a small chance of a permanent harm.

Some of it is fatigue with the cycle. Temporary fillers need repeating. The NHS range of 6 to 18 months means a maintenance rhythm that some people eventually find more tedious than the result is worth.

And some of it is honest uncertainty about the long term. As discussed above, imaging findings of filler lasting far longer than labeled have made a portion of long-term users reconsider how much product is actually in their faces.

What the evidence does not show is a wave of people stopping because of new proof that fillers are unsafe. Complication rates have not been shown to be rising. The change is better described as a maturing of expectations: fewer people treating filler as trivial, more treating it as a medical procedure with a real, if small, downside.

How injectors reduce risk, and what dissolving a filler involves

Most of what protects a patient happens before the syringe is opened. A thorough injector takes a history that covers allergies, clotting, autoimmune disease, recent infections and dental work, and previous filler including what and where. They examine the face for scars from prior treatments, which can distort normal vessel pathways, and they talk through which areas they consider high risk.

Technique matters. Several practices are widely taught to reduce the chance of injecting into an artery: aspirating, which means pulling back on the syringe to check for blood before injecting; using blunt cannulas rather than sharp needles in certain zones; injecting slowly and in small amounts; and keeping the needle moving rather than depositing a large bolus in one spot. None of these eliminates risk, and the evidence for each is stronger in expert consensus than in randomized trials, but together they represent current good practice.

The other half of safety is preparedness. For hyaluronic acid fillers, an enzyme called hyaluronidase can break the gel down within hours. It is the primary treatment for a vascular occlusion and for correcting lumps, migration or unwanted results. Its availability on the premises, and the injector’s training and legal authority to use it immediately, are the questions that matter most. A clinic that has to send you elsewhere to obtain it is a clinic that has added hours to a situation measured in minutes. How much is used, and how often, is a clinical judgment for the treating practitioner based on the situation in front of them.

Hyaluronidase does not work on calcium hydroxylapatite, poly-L-lactic acid or permanent fillers, which is one reason many clinicians reserve those products for lower-risk areas and experienced hands. Some people are allergic to the enzyme itself, so its use also carries a small risk that the injector should be prepared to manage.

What people often get wrong about filler side effects

Myth: a bruise that hurts is a sign of occlusion. Bruises are tender, especially in the lips, and tenderness alone is not a red flag. The distinguishing features are pain at rest that worsens rather than eases, and skin that turns pale or lacy rather than purple and uniform. Both together are far more telling than either alone.

Myth: hyaluronic acid is “natural”, so reactions are impossible. The molecule is natural; the product is a chemically stabilized gel with cross-linking agents, and delayed inflammatory reactions, though uncommon, are well documented. Natural origin is not a safety guarantee.

Myth: filler disappears completely on schedule. As discussed, imaging has repeatedly found material persisting years beyond the labeled duration. Assume some residue when planning repeat treatments.

Myth: if the injector is a doctor, the risk is negligible. Qualification matters enormously, but anatomy does not read credentials. The published cases of blindness include injections by experienced physicians. Training reduces risk; it does not abolish it.

Myth: massaging a lump will fix it. Sometimes an injector will ask you to massage in a specific way for a specific period. Unprompted rubbing can move gel into places it should not be and can worsen swelling. Ask first.

Myth: vision changes would be obvious and instant. Many cases involve blurring, a gray shadow or eye pain that people initially attribute to anxiety or a headache. Any visual symptom after an injection near the eyes, nose or forehead is an emergency until proven otherwise.

Myth: dissolving is a guaranteed reset. Hyaluronidase is highly effective for hyaluronic acid but does nothing for other filler types, can cause its own reactions, and may leave the area looking temporarily deflated. It is a treatment with its own consent conversation, not an eraser.

Questions to ask your care team

A consultation is a two-way examination. You are assessing whether this person, in this room, has the training and the safety net to look after you if the rare thing happens. These questions tend to reveal that quickly.

• What exactly is the product, and is it a temporary hyaluronic acid filler or something else? If something else, why, and how would a problem be corrected?
• Which areas of my face do you consider high risk, and how does your technique change in those areas?
• Do you keep hyaluronidase on the premises, are you trained and authorized to use it immediately, and how would I reach you outside opening hours?
• How will I be able to contact a clinician tonight or over the weekend if I notice pain, color change or vision symptoms?
• What should I expect to see on day one, day three and day ten, and what would make you want to see me sooner?
• Have I had filler before that might still be present, and does that change your plan?
• Is there anything in my medical history, medicines or supplements that you would like me to discuss with my prescribing doctor before we proceed?
• If I am unhappy with the result, what is your approach to adjustment or dissolving, and what is the typical timeline for each?
• Are you registered with a professional regulator, and does your insurance cover the management of complications?

Notice what is not on the list: nothing about how the result will look in a photograph. That conversation matters, but it is the easy half. The questions above are the ones a nervous person forgets to ask and a well-prepared practitioner is glad to answer. If any of them meet vagueness or irritation, that reaction is information too.

When to call your doctor

Most people will never need this section. Read it anyway, before treatment rather than after, so the signs are familiar if they appear.

Contact your injector the same day, or go to an emergency department if you cannot reach them promptly, for any of the following: skin over or near the treated area that has turned white, gray or a dusky purple with a lacy, net-like pattern; pain that is deep, burning or throbbing at rest and getting worse rather than better; skin that stays pale after you press and release it; blistering, darkening or breakdown of the skin surface in the hours or days after treatment; or a sense that the area is numb while the surrounding skin is painful.

Treat as an emergency, without waiting to reach the clinic first, any change in vision after an injection anywhere on the face, including blurring, a shadow or curtain across part of your sight, double vision, eye pain, or sudden severe headache. Sudden weakness, difficulty speaking or facial drooping on one side also need emergency services immediately.

Arrange an appointment within a day or two for a lump that is hot, red, enlarging or draining; fever or feeling unwell after treatment; swelling that continues to increase after the second day; or a bruise that keeps spreading rather than fading.

Book a routine review for firm or visible lumps that persist beyond two weeks, bluish discoloration, asymmetry, or filler that appears to have moved. These are rarely urgent but are easier to address early.

In every case, the injector or the doctor assessing you decides what happens next. Your job is only to notice and to call, and to err on the side of calling. No competent practitioner will think less of a patient for reporting a symptom that turned out to be a bruise.

Frequently asked questions

What are the most common dermal filler side effects?

Bruising, swelling, redness and tenderness at the injection site are by far the most common, and patient guidance from the NHS and the Cleveland Clinic describes them as expected rather than as complications. Small lumps that soften over one to two weeks are also frequent, especially in the lips. Serious problems such as infection, vascular blockage or vision loss are uncommon, but they are the ones that shape how carefully the procedure should be approached.

How long does filler bruising last?

Most bruising and swelling settles within days to about two weeks, according to patient guidance from the Cleveland Clinic and the NHS, with lips and the under-eye area often at the longer end. A normal bruise darkens, then shifts through green and yellow before fading. A bruise that keeps spreading after the first couple of days, or that is accompanied by worsening pain or pale, lacy skin, should be reported to your injector the same day.

What are the filler vascular occlusion signs I should know?

The key signs are skin turning white, gray or a dusky lacy purple; deep, burning or throbbing pain that persists or worsens at rest; skin that stays pale after being pressed and released; and, later, blistering or darkening. Any vision change after facial injection is a separate emergency. These signs can appear within minutes to hours. Brief blanching without pain right after injection is often the anesthetic in the filler, but persistent blanching is not.

What is the riskiest place for fillers?

The glabella (between the eyebrows), the nose, the nasolabial folds and the forehead carry the highest reported risk of vision loss because their arteries connect to the vessels behind the eye. A PubMed-indexed review of 98 cases of blindness after filler found the glabella involved in 38.8 percent and the nose in 25.5 percent. The lips, nose and temples are the areas most often reported for skin necrosis without eye involvement.

What are the long-term side effects of fillers?

For temporary hyaluronic acid fillers, well-documented long-term issues include filler persisting for years beyond its labeled duration, recurrent puffiness under the eyes, migration around the lips and occasional delayed inflammatory nodules. Permanent fillers carry the clearest long-term risk because granulomas or displacement cannot be dissolved and may need surgery. Claims that fillers stretch the skin or destroy collagen have not been demonstrated in controlled studies, but decades-long data are limited.

Are lip filler side effects different from other areas?

Lips swell more and bruise more readily than most areas because the tissue is loose and richly supplied with blood, so a fuller-than-expected look on day one or two is normal. Lips are also among the areas most often reported for migration of filler above the border and for skin necrosis, since a large artery runs close to where filler is commonly placed. Pain at rest, pale or dusky patches or blistering on the lip need same-day attention.

Are fillers more risky than botulinum toxin injections?

They carry different kinds of risk. Botulinum toxin is a medicine that temporarily relaxes muscle; its side effects, such as a drooping eyelid or uneven smile, come from spread to nearby muscles and fade as the effect wears off over a few months. Fillers are a physical material placed near arteries, so their rare serious risks, skin necrosis and vision loss, can be permanent. Both are considered low risk in trained hands, but the worst-case outcomes differ.

Why are people stopping fillers?

Reported reasons include dissatisfaction with a fuller or heavier appearance after repeated treatments, lip borders blurred by migration, fatigue with the 6 to 18 month maintenance cycle described by the NHS, greater awareness of rare vascular complications, and imaging reports of filler persisting far longer than labeled. These are shifts in preference and information rather than evidence of rising complication rates, which have not been shown to be increasing.

Can dermal filler side effects be reversed?

Many can, depending on the product. Hyaluronic acid filler can be broken down with an enzyme called hyaluronidase, which is used both for emergencies such as vascular occlusion and for correcting lumps, migration or an unwanted result. Calcium hydroxylapatite, poly-L-lactic acid and permanent fillers cannot be dissolved this way, so problems with those products are harder to correct. Whether and how to use the enzyme is a decision for the treating clinician.

How long after filler can a serious side effect appear?

Vascular occlusion usually announces itself within minutes to hours of injection, though skin breakdown can evolve over several days. Infection typically appears within the first one to two weeks. Delayed inflammatory nodules and biofilm reactions can surface weeks to months later, sometimes after an unrelated illness, dental work or vaccination. Any new lump, color change or persistent pain in a previously treated area is worth an in-person review, whenever it occurs.

References

• NHS: Dermal fillers (non-surgical cosmetic procedures)
• Cleveland Clinic: Dermal Fillers

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.